Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery
SONEW
SONEW
Sponsor study identifier
interventional
30
0 countries
N/A
Study Start
July 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2010
Actual (reported)Study Completion
January 2011
Actual (reported)The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to perform kaolin-based activated clotting time as routine monitor of heparin therapy in patients undergoing cardiac operations. In addition, the device allows the assessment of the patient's coagulation status by a glass-bead activated test. Recently, a new SONOCLOT analyzer (S2) has been developed. As part of the routine management using S1, tests are also performed on S2. Results are entered into the cardiac surgery data base of all cardiac surgery patients and analyzed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2009
Date type not reportedThis date has not been verified as actual or estimated.
January 2010
Actual (reported)January 2011
Actual (reported)October 23, 2015
Actual (reported)October 28, 2015
Actual (reported)April 3, 2018
Actual (reported)Kaolin-activated Clotting Time
Routine measurements during cardiac surgery
Glass Bead Activated Clotting Time
Routine measurements during cardiac surgery
ACT measurements by SONOCLOT Analyzer during cardiac surgery
Blood coagulation test during cardiac surgery: Measurement of activated clotting time during cardiac surgery by Sonoclot Analyzer
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008 May;106(5):1366-75. doi: 10.1213/ane.0b013e318168b367.
Michele Genoni, MD
Triemli City Hospital
30 participants (actual enrollment reported by the registry).
First Submitted
October 23, 2015
First Posted
October 28, 2015
Study Start
July 2009
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
January 2010
Actual (reported)Study Completion
January 2011
Actual (reported)Last Updated
May 4, 2018
Results First Posted
April 3, 2018
Record last verified: 2018-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: